应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
03696 英矽智能
休市中 05-15 16:09:05
52.950
-5.300
-9.10%
最高
59.700
最低
52.300
成交量
484.97万
今开
58.600
昨收
58.250
日振幅
12.70%
总市值
302.67亿
流通市值
302.67亿
总股本
5.72亿
成交额
2.62亿
换手率
0.85%
流通股本
5.72亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
英矽智能与瑞博生物达成战略合作：整合AI平台与自动化实验室，赋能RNA干扰与寡核苷酸疗法全流程开发
美股速递 · 05-12
英矽智能与瑞博生物达成战略合作：整合AI平台与自动化实验室，赋能RNA干扰与寡核苷酸疗法全流程开发
异动解读 | 英矽智能盘中大涨5.05%，与Google Cloud合作加速药物发现进程
异动解读 · 05-11
异动解读 | 英矽智能盘中大涨5.05%，与Google Cloud合作加速药物发现进程
港股异动 | 英硅智能(03696)盘中涨近4% 近日与Google Cloud合作 进一步增强靶点发现与核心研发流程
智通财经 · 05-11
港股异动 | 英硅智能(03696)盘中涨近4% 近日与Google Cloud合作 进一步增强靶点发现与核心研发流程
英矽智能4月股份变动月报表，股本维持稳定
公告速递 · 05-07
英矽智能4月股份变动月报表，股本维持稳定
港股异动 | 英硅智能(03696)盘中涨超5% 正式发布最新一代智能实验室操作系统LabClaw
智通财经 · 05-07
港股异动 | 英硅智能(03696)盘中涨超5% 正式发布最新一代智能实验室操作系统LabClaw
英硅智能(03696)认购理财产品
智通财经 · 04-30
英硅智能(03696)认购理财产品
英矽智能及其子公司于2026年4月29日认购理财产品
美股速递 · 04-30
英矽智能及其子公司于2026年4月29日认购理财产品
英矽智能获NMPA药品审评中心批准吸入式Rentosertib新药临床试验申请
美股速递 · 04-29
英矽智能获NMPA药品审评中心批准吸入式Rentosertib新药临床试验申请
英矽智能拟回购不超已发行股本10%股份
公告速递 · 04-28
英矽智能拟回购不超已发行股本10%股份
英矽智能2025年业绩：AI平台多项升级，收入下滑34.5%，净资产大幅扭转为正
公告速递 · 04-28
英矽智能2025年业绩：AI平台多项升级，收入下滑34.5%，净资产大幅扭转为正
AI 赋能区域药物研发 英硅智能(03696)阿联酋团队提名首款临床前候选药物
智通财经 · 04-24
AI 赋能区域药物研发 英硅智能(03696)阿联酋团队提名首款临床前候选药物
港股异动 | 英硅智能(03696)涨幅扩大逾10% 公司成立业界首个长寿委员会 礼来分子发现集团副总裁任主席
智通财经 · 04-22
港股异动 | 英硅智能(03696)涨幅扩大逾10% 公司成立业界首个长寿委员会 礼来分子发现集团副总裁任主席
异动解读 | 英矽智能盘中大涨5.19%，因将携AI临床前研究成果亮相AACR大会
异动解读 · 04-22
异动解读 | 英矽智能盘中大涨5.19%，因将携AI临床前研究成果亮相AACR大会
英硅智能(03696)午后持续上扬13.73% 药物靶点发现统一AI框架取得新进展
金吾财讯 · 04-20
英硅智能(03696)午后持续上扬13.73% 药物靶点发现统一AI框架取得新进展
港股异动 | 英矽智能涨超14%，在AI驱动研发方面取得显著进展
智通财经 · 04-20
港股异动 | 英矽智能涨超14%，在AI驱动研发方面取得显著进展
异动解读 | 英矽智能盘中大涨8.47%，AACR年会泛KRAS研究成果与AI制药平台进展双重利好
异动解读 · 04-20
异动解读 | 英矽智能盘中大涨8.47%，AACR年会泛KRAS研究成果与AI制药平台进展双重利好
英硅智能(03696)授出370.69万份受限制股份单位
智通财经 · 04-14
英硅智能(03696)授出370.69万份受限制股份单位
英矽智能3月股份变动月报表：股本维持稳定
公告速递 · 04-09
英矽智能3月股份变动月报表：股本维持稳定
异动解读 | 英矽智能盘中大涨8.98%，新药候选化合物提名及与礼来合作提振股价
异动解读 · 04-09
异动解读 | 英矽智能盘中大涨8.98%，新药候选化合物提名及与礼来合作提振股价
港股异动 | 英硅智能(03696)早盘涨超9% 公司提名潜在“同类最佳”NR3C1选择性拮抗剂ISM6200
智通财经 · 04-09
港股异动 | 英硅智能(03696)早盘涨超9% 公司提名潜在“同类最佳”NR3C1选择性拮抗剂ISM6200
公司概况
公司名称：
英矽智能
所属市场：
SEHK
上市日期：
--
主营业务：
英矽智能是一家主要从事人工智能在制药领域研发的公司。该公司致力于药物发现引擎的研发，并从事联合用药的发现和开发，包括疾病靶点识别、新分子数据生成以及临床试验结果预测。
发行价格：
--
{"stockData":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"英矽智能","latestPrice":52.95,"timestamp":1778832545008,"preClose":58.25,"halted":0,"volume":4849690,"delay":0,"changeRate":-0.09098712446351927,"floatShares":571622000,"shares":571622000,"eps":-35.09129218983763,"marketStatus":"休市中","change":-5.3,"latestTime":"05-15 16:09:05","open":58.6,"high":59.7,"low":52.3,"amount":261950782,"amplitude":0.127039,"askPrice":52.95,"askSize":1500,"bidPrice":52.75,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-37.519484283330854,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":7,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":58.25,"openAndCloseTimeList":[[1778808600000,1778817600000],[1778821200000,1778832000000]],"volumeRatio":1.6298142665373774,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03696/wiki","defaultTab":"wiki","newsList":[{"id":"1153082779","title":"英矽智能与瑞博生物达成战略合作：整合AI平台与自动化实验室，赋能RNA干扰与寡核苷酸疗法全流程开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1153082779","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153082779?lang=zh_cn&edition=full","pubTime":"2026-05-12 20:32","pubTimestamp":1778589132,"startTime":"0","endTime":"0","summary":"英矽智能与瑞博生物宣布签署战略合作协议，双方将整合各自在人工智能药物发现平台与自动化实验室方面的核心优势，旨在为RNA干扰及寡核苷酸疗法的研发提供从早期发现到临床前研究的端到端赋能。\n此次合作将依托英矽智能领先的生成式人工智能平台，结合瑞博生物在核酸药物领域的深厚积累与自动化实验能力，共同加速创新疗法的开发进程。双方期望通过这一深度协作，显著提升靶点发现、分子设计及优化等关键环节的效率与成功率，从而推动下一代核酸治疗药物的突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184273570","title":"异动解读 | 英矽智能盘中大涨5.05%，与Google Cloud合作加速药物发现进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1184273570","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184273570?lang=zh_cn&edition=full","pubTime":"2026-05-11 11:45","pubTimestamp":1778471119,"startTime":"0","endTime":"0","summary":"英矽智能今日盘中大涨5.05%，引起了市场的广泛关注。消息面上，公司近日宣布与Google Cloud达成合作，旨在加速其药物发现进程。通过此次合作，英矽智能将结合自有Pharma.AI平台，利用Google Cloud可扩展的计算基础设施与先进AI能力，提升药物发现流程的速度与效率。具体而言，英矽智能计划在其产品体系中集成Gemini Enterprise Agent Platform及Google Gemini系列模型，其中包括将Gemini与公司最新工具PandaClaw相结合，以进一步增强靶点发现与核心研发流程。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634473075","title":"港股异动 | 英硅智能(03696)盘中涨近4% 近日与Google Cloud合作 进一步增强靶点发现与核心研发流程","url":"https://stock-news.laohu8.com/highlight/detail?id=2634473075","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634473075?lang=zh_cn&edition=full","pubTime":"2026-05-11 10:36","pubTimestamp":1778466970,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英硅智能盘中涨近4%，截至发稿，涨2.33%，报65.8港元，成交额6139.74万港元。消息面上，据英硅智能官微消息，近日，公司宣布与Google Cloud合作，旨在加速其药物发现进程。通过此次合作，英硅智能将结合自有Pharma.AI平台，利用Google Cloud可扩展的计算基础设施与先进AI能力，提升药物发现流程的速度与效率。其中包括将Gemini与英硅智能最新工具PandaClaw结相合，进一步增强靶点发现与核心研发流程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999015986.USD","LU0138981039.USD","LU2360032135.SGD","LU0070217475.USD","LU1037948541.HKD","LU0786609619.USD","LU0345770993.USD","LU1116320737.USD","HK0000304805.HKD","LU0976567544.SGD","LU1642822529.SGD","IE0009356076.USD","LU0133085943.USD","LU0251142724.SGD","LU2242650005.HKD","IE00BJLML261.HKD","IE00B1XK9C88.USD","LU0476273544.USD","LU2125909247.SGD","LU1066051498.USD","LU2168564222.USD","LU0289961442.SGD","LU0106261372.USD","LU1366192091.USD","LU1951198990.SGD","LU0187121727.USD","LU0097036916.USD","IE00BK4W5M84.HKD","BK1141","LU0289739343.SGD","SG9999015978.USD","LU2860962120.EUR","LU0203202063.USD","LU2087625088.SGD","LU0689626769.HKD","BK4525","IE0034235295.USD","LU0210533765.USD","BK4538","BK4507","LU2462157665.USD","LU0477156797.USD","LU1069347547.HKD","LU1917777945.USD","LU0211326839.USD","LU0957808578.USD","LU1923622614.USD","LU1201861165.SGD","LU1145028129.USD","BK4588","LU0107464264.USD","IE00BMPRXQ63.HKD","GB00B4QBRK32.GBP","LU0251132253.USD","LU2361044949.HKD","LU0511384066.AUD","BK4532","LU2362540622.SGD","LU2471134523.USD","LU0211326755.USD","LU1201861249.SGD","LU1951200564.SGD","IE00B1BXHZ80.USD","BK4573","LU0211327993.USD","LU2491050071.SGD","LU1032955483.USD","LU1815336760.USD","LU2077746001.SGD","LU0882574139.USD","IE00BJTD4V19.USD","LU0494093205.USD","LU0708995401.HKD","LU1066051225.USD","LU1935043536.SGD","LU2264538146.SGD","LU0312595415.SGD","LU0985320562.USD","SG9999014880.SGD","SG9999018857.SGD","LU0256863811.USD","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0314104364.USD","LU0949170426.SGD","LU1718418525.SGD","LU1429558221.USD","LU2065169927.USD","LU2487616109.SGD","IE000SO60NU8.SGD","LU2362541273.HKD","LU2954938101.SGD","LU0314106906.USD","LU0077335932.USD","LU1066051811.HKD","BK4553","LU2237443622.USD","BK4576","LU2237443978.SGD","LU2360106780.USD","LU0943347566.SGD","LU2237443895.HKD","LU0082616367.USD","LU2433249047.HKD","IE00B775H168.HKD","LU0265550946.USD","LU0426412945.USD","LU0310800379.SGD","LU1267930730.SGD","LU0690374961.EUR","LU0426417589.USD","LU2461242641.AUD","LU0302445910.USD","LU2764263039.SGD","IE00BJJMRX11.SGD","LU0965509101.SGD","LU2023250843.SGD","LU1989772923.USD","SG9999014898.SGD","LU1548497426.USD","LU0072462426.USD","LU1720051108.HKD","IE00BN29S564.USD","LU1316542783.SGD","LU1935042991.SGD","IE00BDRTCR15.USD","LU2720916845.USD","LU1035773651.USD","LU0545039389.USD","LU1244550494.USD","LU1121112475.USD","HK0000532082.HKD","LU1244550221.USD","LU2097829019.USD","LU1720051017.SGD","LU1989772840.SGD","LU0310799852.SGD","LU0158827781.USD","IE00BFMHRM44.USD","LU1046421795.USD","LU2089283258.USD","LU2362541513.USD","LU2458330169.SGD","LU1935042488.USD","LU0345774391.USD","GOOX","LU0784385840.USD","LU2111349929.HKD","BK4561","IE00BWXC8680.SGD","HK0000304797.USD","LU1914381329.SGD","LU0708994859.HKD","META","LU2458330243.SGD","LU0070302665.USD","NVDA","LU2404859667.USD","IE0004091025.USD","LU0861579265.USD","LU2168564149.EUR","SG9999018865.SGD","LU0661504455.SGD","LU2357305700.SGD","LU1496350171.SGD","SG9999015945.SGD","LU1267930490.SGD","LU0308772762.SGD","IE000WAW04H5.SGD","BK4612","LU2403377893.USD","LU0859254822.USD","LU2543165471.USD","LU2065171311.SGD","LU0048573561.USD","LU0985489474.SGD","LU0823421416.USD","BK4514","BK4602","LU0823434740.USD","LU1267930227.SGD","LU0143551892.USD","GGLS","LU0203347892.USD","LU0289960550.SGD","IE00BKPKM429.USD","IE00B3S45H60.SGD","LU1196500208.SGD","LU1066053197.SGD","LU1153585028.USD","LU0128525929.USD","LU0980610538.SGD","SG9999002232.USD","SGXZ51526630.SGD","IE00BYXW3230.USD","LU1003077747.HKD","BK4574","GOOP","03696","LU0642271901.SGD","LU1633808545.USD","LU2361044865.SGD","LU0158827948.USD","LU2098885051.SGD","LU0965509283.SGD","LU1506573853.SGD","LU0053666078.USD","LU1301847155.USD","IE00B775SV38.USD","LU0345774631.USD","LU2168563687.JPY","LU1496350502.SGD","BK4533","LU2237443549.SGD","LU0787776722.HKD","LU1571399168.USD","LU2552382215.SGD","LU2125909593.SGD","IE0034235188.USD","LU0820562030.AUD","LU2271345857.HKD","LU0648000940.SGD","LU0265550359.USD","LU1400636657.SGD","LU0130103400.USD","LU0157215616.USD","LU1868836914.USD","LU0820561818.USD","BK4587","LU0011850046.USD","LU2097344431.USD","LU0289941410.SGD","SG9999014567.USD","LU2265009873.SGD","SG9999015952.SGD","LU1868836757.USD","LU0130517989.USD","LU2430703095.HKD","LU1670627923.USD","LU0130518102.USD","LU0690374615.EUR","LU0957791311.USD","IE00BBT3K403.USD","LU2505996509.AUD","LU2087621335.USD","LU0211331839.USD","LU1691799644.USD","LU1989764748.USD","LU2491050154.USD","LU1261432733.SGD","LU1791710400.SGD","IE00BSNM7G36.USD","LU0068578508.USD","LU1489326972.SGD","LU2357627491.SGD","LU2462591350.SGD","LU1303367103.USD","LU1221951046.USD","LU1043141396.HKD","LU1280957306.USD","LU1823568750.SGD","LU1988902786.USD","LU2764262908.HKD","IE00BYQQ9H92.USD","LU1934455194.USD","LU0210536198.USD","LU2471134879.HKD","LU0672654240.SGD","IE0001KFT4U8.USD","LU2023250504.SGD","LU1221951129.SGD","LU1815333072.USD","LU0109391861.USD","LU2108987350.USD","LU0742534661.SGD","LU0203201768.USD","LU0784383803.USD","LU0052756011.USD","LU1551013342.USD","IE00B4JS1V06.HKD","LU2023251221.USD","LU0061475181.USD","LU2471134796.USD","IE00BFSS7M15.SGD","LU2028103732.USD","BK4548","BK4598","LU0965508806.USD","LU0528227936.USD","LU2275660780.HKD","LU0553294199.USD","USJW.SI","IE00B19Z8W00.USD","LU2552382058.USD","BK4592","LU1084165304.USD","LU1674673691.USD","BK4585","LU2168564065.EUR","LU0061474705.USD","LU0689472784.USD","LU1235294995.USD","LU0096364046.USD","SG9999014906.USD","LU0057025933.USD","LU0203345920.USD","LU2361045086.USD","BK4550","IE00B19Z9505.USD","LU1934455863.HKD","SG9999014575.USD","LU1880398471.USD","LU0198837287.USD","LU0889566641.SGD","LU0348723411.USD","LU0069063385.USD","LU0724617625.USD","LU0175139822.USD","LU2491049909.HKD","LU0154236417.USD","LU2756315318.SGD","BK4503","LU2456880835.USD","LU0174119429.USD","LU0130102774.USD","SG9999014559.SGD","BK4566","LU1868837300.USD","HK0000819398.USD","LU2247934214.USD","LU1400636491.USD","LU2999663052.SGD","IE00BLSP4452.SGD","LU0342679015.USD","LU0889565833.HKD","IE0034235303.USD","LU0061474960.USD","LU0320765059.SGD","LU0345768740.USD","LU2106854487.HKD","LU0719512351.SGD","LU2065171402.SGD","LU2750360997.AUD","LU1043141123.HKD","LU1119994496.HKD","LU2125154778.USD","LU2592432038.USD","SG9999014542.SGD","LU1935043023.USD","LU0784384876.USD","LU0256863902.USD","LU1778281490.HKD","LU0949170772.SGD","IE00BFSS8Q28.SGD","LU2168564495.EUR","LU0276348264.USD","LU0323591593.USD","LU0127658192.USD","LU2092937148.SGD","LU2505996681.GBP","GOU","IE00BQXX3C00.GBP","LU1323610961.USD","LU0029864427.USD","LU1804176565.USD","LU1814569148.SGD","LU0648001328.SGD","LU0210528500.USD","IE000MB6IJN5.SGD","IE00B7SZLL34.SGD","SGXZ31699556.SGD","LU1551013425.SGD","LU0823434583.USD","LU1934455277.USD","IE00BJTD4N35.SGD","SG9999017495.SGD","IE00BHPRN162.USD","LU2746668974.SGD","LU1629891620.HKD","LU1868837136.USD","BK4534","LU0345769631.USD","LU2242649171.HKD","IE00B5949003.HKD","LU2236285917.USD","LU2244417387.USD","LU0942090050.USD","LU2746668461.USD","LU2602419157.SGD","LU0149725797.USD","LU1670756490.USD","LU2637965513.SGD","LU0472753341.HKD","LU2764263203.CNY","BK4579","IE00B19Z3B42.SGD","LU0496365809.HKD","LU0215105999.USD","LU1585245621.USD","LU1674673428.USD","LU1074936037.SGD","LU1267930813.SGD","LU0211328371.USD","LU0354030438.USD","LU1267930573.SGD","LU1868836591.USD","BK4077","IE0004086264.USD","IE00BQXX3D17.EUR","LU1935042215.USD","LU0128525689.USD","LU0048584097.USD","LU1435385759.SGD","LU1116320901.HKD","BK4527","LU1894683348.USD","AAPL","LU2125154935.USD","LU2213496289.HKD","IE00BDCRKT87.USD","LU2381873111.SGD","LU2552382132.HKD","LU1400636574.HKD","SG9999014914.USD","IE000BZT7R73.USD","LU0823421333.USD","LU0109392836.USD","LU0056508442.USD","LU0466842654.USD","IE0004445239.USD","LU2023250330.USD","LU1127390331.HKD","LU2286300806.USD","LU1791710582.SGD","LU0788109477.HKD","LU2089284900.SGD","LU0170899867.USD","IE00BQXX3F31.USD","LU2065170008.USD","LU2092627202.USD","LU1232071149.USD","LU0444971666.USD","LU0251131958.USD","IE00BZ1G4Q59.USD","IE0005OL40V9.USD","LU2326559502.SGD","TSLA","LU1852331112.SGD","LU2097344357.USD","LU2417539215.USD","LU0417517546.SGD","LU2430703251.USD","LU0792757196.USD","IE00BK4W5L77.USD","LU1974910355.USD","IE00B5TLWC47.USD","LU0006306889.USD","BK4581","LU0225283273.USD","LU2250418816.HKD","LU0080751232.USD","LU1202635105.USD","LU1670628061.USD","LU0477156953.USD","LU0079474960.USD","IE00BMPRXR70.SGD","LU0234572021.USD","LU2430703178.SGD","LU0964807845.USD","LU1803068623.USD","SG9999015341.SGD","LU2420271590.USD","SG9999000418.SGD","IE00BMPRXN33.USD","SG9999002224.SGD","LU1430594728.SGD","IE00BLSP4239.USD","LU0557290698.USD","LU0094547139.USD","LU1244550577.SGD","LU2756315664.SGD","LU0234570918.USD","IE0002270589.USD","LU0345769128.USD","LU0994945656.USD","LU0640476718.USD","IE000F7OJYX1.SGD","LU0354030511.USD","LU0820561909.HKD","LU0444973449.USD","LU0316494557.USD","LU2191332357.HKD","LU1894683264.USD","LU0868494617.USD","LU1064131342.USD","LU0124676726.USD","IE00B7KXQ091.USD","SGXZ81514606.USD","IE00BFXG0V08.USD","IE00BZ199S13.USD","LU1923623000.USD","SG9999015358.SGD","IE00B19Z8X17.USD","IE00BKVL7J92.USD","LU0433182093.SGD","LU1069344957.HKD","LU1880398554.USD","LU2471134952.CNY","LU0208291251.USD","LU0878866978.SGD","MSFT","LU0238689110.USD","BK4554","IE00BN8TJ469.HKD","SGXZ99366536.SGD","LU0345770308.USD","LU1037948897.HKD","LU0868494708.USD","LU1035775433.USD","LU2750360641.GBP","GB00B4LPDJ14.GBP","GOOW","LU1366333091.USD","LU0353189763.USD","BK4543","IE00BKDWB100.SGD","LU0320765489.SGD","IE0000B7K699.USD","LU1059921491.USD","LU0096362180.USD","LU1989764664.SGD","GOOY","LU0784385170.HKD","SG9999001077.SGD","LU1839511570.USD","LU0738911758.USD","LU0310800965.SGD","IE0004445015.USD","LU2463028550.USD","LU1803068979.SGD","LU2054465674.USD","LU0353189680.USD","LU2211815571.USD","GGLL","LU2462591277.SGD","LU0965509010.AUD","AMZN","LU0267386448.USD","LU1645745479.HKD","LU0456855351.SGD","LU1699723380.USD","LU0345768153.USD","LU2063271972.USD","LU2237443465.HKD","LU2404859741.USD","LU2237438978.USD","LU2896262040.SGD","IE00BJJMRY28.SGD","LU0683600562.USD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142779702","title":"英矽智能4月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1142779702","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142779702?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:46","pubTimestamp":1778147197,"startTime":"0","endTime":"0","summary":"英矽智能于2026年5月7日披露截至2026年4月30日的股份变动月报表。报告期内，公司法定注册股本总数维持1,270,000,000股，面值每股0.0000005美元，法定/注册股本为635美元，与上月均无变动。截至本月末，英矽智能普通股合计已发行股份数为572,402,000股，库存股份数为0股，较上月相比未发生新增发行、购回或注销等变动。公司表示已遵守香港联合交易所有限公司《上市规则》及其他适用法律法规，并确认截至本月底发行人股本结构整体保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633193439","title":"港股异动 | 英硅智能(03696)盘中涨超5% 正式发布最新一代智能实验室操作系统LabClaw","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193439","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633193439?lang=zh_cn&edition=full","pubTime":"2026-05-07 11:46","pubTimestamp":1778125580,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英硅智能盘中涨超5%，截至发稿，涨2.69%，报62.95港元，成交额7599.63万港元。消息面上，5月7日，据英硅智能官微消息，公司宣布正式发布最新一代智能实验室操作系统LabClaw。通过5个协作式AI智能体与28项专业技能模块，LabClaw成功构建了从疾病靶点发现、化合物筛选、自动化实验执行到数据分析与报告生成的干湿实验全链路智能闭环。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438926.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","03696","BK4588","BK4585","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631575091","title":"英硅智能(03696)认购理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2631575091","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631575091?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:12","pubTimestamp":1777507975,"startTime":"0","endTime":"0","summary":"于认购理财产品前，英硅智能香港已于2026年4月14日下达订单认购上述由 JPMorgan Asset Management S.a.r.l管理的美元标准货币市场VNAV基金，认购本金额为200万美元，而其于紧接认购理财产品前的尚未赎回结余为200万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151319430","title":"英矽智能及其子公司于2026年4月29日认购理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1151319430","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151319430?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:06","pubTimestamp":1777507575,"startTime":"0","endTime":"0","summary":"英矽智能（Insilico Medicine Cayman Topco）与其旗下子公司于2026年4月29日共同完成了对理财产品的认购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168179730","title":"英矽智能获NMPA药品审评中心批准吸入式Rentosertib新药临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1168179730","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168179730?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:03","pubTimestamp":1777421031,"startTime":"0","endTime":"0","summary":"英矽智能（Insilico Medicine Cayman Topco）宣布，其吸入式Rentosertib的新药临床试验（IND）申请已获得中国国家药品监督管理局（NMPA）药品审评中心（CDE）的批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127647365","title":"英矽智能拟回购不超已发行股本10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1127647365","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127647365?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:12","pubTimestamp":1777378352,"startTime":"0","endTime":"0","summary":"英矽智能公告称，将于2026年6月2日以电子会议方式召开股东周年大会，审议并批准一项股份购回授权。根据公告，该授权上限为公司已发行股本的10%，即最多可回购约57,240,200股股份。董事会表示，回购预计使用公司内部联系汇集的内部资源，在符合开曼群岛法律及香港上市规则等相关法规的要求下进行。董事会认为，股份购回可提升每股资产净值及优化资本结构，符合公司及股东利益。公告显示，英矽智能于2025年12月30日在香港上市。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"英矽智能拟回购不超已发行股本10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116825646","title":"英矽智能2025年业绩：AI平台多项升级，收入下滑34.5%，净资产大幅扭转为正","url":"https://stock-news.laohu8.com/highlight/detail?id=1116825646","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116825646?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:10","pubTimestamp":1777378210,"startTime":"0","endTime":"0","summary":"英矽智能在2025年实现香港联合交易所主板上市，引入15家战略及机构投资者，为其人工智能药物研发业务提供了资金与资源支持。报告期内，公司进一步升级了端到端式人工智能平台Pharma.AI，分别强化Biology42、Chemistry42和Science42三大核心模块。2025年公司收入约为5,623.9万美元，较2024年的8,583.4万美元下降34.5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"英矽智能2025年业绩：AI平台多项升级，收入下滑34.5%，净资产大幅扭转为正","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629586299","title":"AI 赋能区域药物研发 英硅智能(03696)阿联酋团队提名首款临床前候选药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2629586299","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629586299?lang=zh_cn&edition=full","pubTime":"2026-04-24 08:10","pubTimestamp":1776989423,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能 公布，英硅智能已正式提名ISM0387为临床前候选药物。ISM0387为一款具备AI赋能设计的新颖结构的MTA协同PRMT5抑制剂，于临床前研究中表现出良好的体外活性及选择性、经优化的透脑特性，并于疾病模型中呈现强劲疗效，且剂量依赖趋势明显。此次提名亦标志着英硅智能迄今为止第30项AI驱动的临床前候选药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","ARTY","03696","AIPO","CHAT","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629093185","title":"港股异动 | 英硅智能(03696)涨幅扩大逾10% 公司成立业界首个长寿委员会 礼来分子发现集团副总裁任主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2629093185","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629093185?lang=zh_cn&edition=full","pubTime":"2026-04-22 11:07","pubTimestamp":1776827249,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英硅智能涨幅扩大逾10%，截至发稿，涨9.73%，报75港元，成交额3.18亿港元。消息面上，英硅智能宣布成立行业首个长寿委员会，旨在为AI赋能的衰老研究与药物发现提供科学监督和战略指导，赋能针对衰老底层生物学机制的药物开发，推动从被动疾病护理向主动健康寿命和巅峰寿命延长的转变。委员会主席由礼来公司分子发现集团副总裁Andrew Adams博士担任，这一关键角色将打通前沿长寿科学与大规模制药研发之间的关键衔接。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1127390331.HKD","LU0006306889.USD","IE00B1BXHZ80.USD","LU1551013425.SGD","LU0354030438.USD","LU2213496289.HKD","LU2112291526.USD","GB00BDT5M118.USD","LU0079474960.USD","LU0210536198.USD","LU1064131342.USD","LU2237443622.USD","LU1035775433.USD","LU2108987350.USD","SG9999014880.SGD","LU1623119135.USD","LU1093756325.SGD","IE00B4JS1V06.HKD","LU2746668974.SGD","LU2361045086.USD","SG9999015952.SGD","LU2023250504.SGD","LU2168564149.EUR","LU0882574139.USD","LU2237443382.USD","SG9999014898.SGD","SG9999017495.SGD","SGXZ31699556.SGD","IE00BKPKM429.USD","LU2168564495.EUR","LU0061475181.USD","LU0456855351.SGD","LU2491049909.HKD","IE00BJJMRZ35.SGD","IE0001KFT4U8.USD","LU0256863811.USD","LU1093756168.USD","LU1366192091.USD","LU1629891620.HKD","LU2750360997.AUD","ELIL","LU2552382215.SGD","LU2417539215.USD","LU0471298777.SGD","BK4581","LU2468319806.SGD","LU2602419157.SGD","LU0094547139.USD","LU1814569148.SGD","SG9999015986.USD","LU2264538146.SGD","IE0009355771.USD","LU2896262040.SGD","LU2756315318.SGD","LU0256863902.USD","IE00BJJMRX11.SGD","LU1917777945.USD","LU2746668461.USD","LU2756315664.SGD","BK4516","LU2357305700.SGD","LU2089284900.SGD","LU0466842654.USD","LU0158827948.USD","IE00BWXC8680.SGD","LU2237443978.SGD","LU1267930730.SGD","LU0823434740.USD","LU2236285917.USD","LU2063271972.USD","LU2461242641.AUD","LU0320765059.SGD","LU2111349929.HKD","SG9999001176.SGD","SG9999018857.SGD","SG9999001176.USD","BK4533","IE00B1XK9C88.USD","LU0820562030.AUD","IE00BJT1NW94.SGD","LU2265009873.SGD","LU0109391861.USD","LU0158827781.USD","LU2237443895.HKD","SG9999014914.USD","IE0002141913.USD","LU1988902786.USD","LU1712237335.SGD","LU0198837287.USD","LU1804176565.USD","LU0203202063.USD","LU0096364046.USD","LU2237438978.USD","LU0106261372.USD","LU0823434583.USD","LU0708995401.HKD","LU2491050071.SGD","IE00BK4W5L77.USD","LU0238689110.USD","LU0354030511.USD","LU1974910355.USD","LU0320765992.SGD","LU2361044865.SGD","IE00BK4W5M84.HKD","SGXZ57979304.SGD","LU0289739699.SGD","LU1291159041.SGD","LU2271345857.HKD","LU0133085943.USD","LU0234572021.USD","IE00BFSS8Q28.SGD","LU2023251221.USD","LU0683600562.USD","LU1868837300.USD","LU2237443465.HKD","BK4585","LU2360106947.USD","LU2456880835.USD","LLII","LU0820561909.HKD","LU2750360641.GBP","LU0058720904.USD","SG9999015945.SGD","LU2361044949.HKD","LU2106854487.HKD","IE0004445239.USD","LU0943347566.SGD","LLYX","LU1983299246.USD","BK4007","LU1280957306.USD","LU0417517546.SGD","LU1069344957.HKD","SG9999015978.USD","IE00BFSS7M15.SGD","LU1720051017.SGD","LU0672654240.SGD","IE00BKDWB100.SGD","IE0004445015.USD","LU0114720955.EUR","LU0882574055.USD","LU1145028129.USD","LU2471134879.HKD","LU2471134523.USD","LU2237443549.SGD","IE00BN29S564.USD","LU0889565916.HKD","LU0353189680.USD","LU0786609619.USD","SGXZ51526630.SGD","SGXZ81514606.USD","03696","LU1548497426.USD","LU2168564065.EUR","SG9999018865.SGD","LU0109394709.USD","LU2028103732.USD","LU2462157665.USD","LU1989771016.USD","LU2552382132.HKD","SG9999013999.USD","LU1023059063.AUD","LU1061106388.HKD","LU1868836591.USD","LU0122379950.USD","LU2168563687.JPY","LU0203201768.USD","IE00B7KXQ091.USD","LU0097036916.USD","LU1720051108.HKD","LU2471134796.USD","LU0820561818.USD","LU2324357040.USD","LU1868836757.USD","BK4599","LU2089984988.USD","LU0689472784.USD","IE00BJJMRY28.SGD","LLYZ","ELIS","LU0385154629.USD","SG9999014906.USD","BK4534","LU1057294990.SGD","LU2023250330.USD","LU2552382058.USD","LU1868837136.USD","LU0640476718.USD","LU0787776722.HKD","BK4588","LU1232071149.USD","LU0353189763.USD","IE00BFTCPJ56.SGD","IE0005OL40V9.USD","IE00BJLML261.HKD","LU0316494557.USD","LU0471298694.HKD","LU1551013342.USD","LU2211815571.USD","LU2087625088.SGD","SGXZ99366536.SGD","LU2491050154.USD","LU0432979614.USD","LU1323610961.USD","LU2168564222.USD","LU0225283273.USD","LU1868836914.USD","LU0823416689.USD","LU2089283258.USD","LU0964807845.USD","IE00B775H168.HKD","IE00B4R5TH58.HKD","BK1141","LU2471134952.CNY","IE00B2B36J28.USD","LU0323591593.USD","LU0266013472.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123642387","title":"异动解读 | 英矽智能盘中大涨5.19%，因将携AI临床前研究成果亮相AACR大会","url":"https://stock-news.laohu8.com/highlight/detail?id=1123642387","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123642387?lang=zh_cn&edition=full","pubTime":"2026-04-22 10:19","pubTimestamp":1776824366,"startTime":"0","endTime":"0","summary":"英矽智能(03696)今日盘中股价大幅上涨5.19%，引起市场关注。消息面上，公司宣布将在2026年美国癌症研究协会(AACR)年会上公布四项AI临床前研究成果，其中包括ISM6166。这标志着英矽智能在生成式人工智能驱动的药物发现领域持续取得进展，增强了投资者对公司创新能力和肿瘤管线前景的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628671948","title":"英硅智能(03696)午后持续上扬13.73% 药物靶点发现统一AI框架取得新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2628671948","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628671948?lang=zh_cn&edition=full","pubTime":"2026-04-20 13:29","pubTimestamp":1776662998,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英硅智能 午后涨幅较早盘有所回落，截至发稿，报69.2港元，涨13.73%，成交额4.75亿港元。今日早盘，其涨幅一度拉升至17.76%。此外，英硅智能还与泰格医药签署了战略合作协议，双方将围绕创新药产品的临床研究开展长期战略合作，合作服务范围全面覆盖临床监查、数据管理与统计分析、医学事务、药物警戒、注册事务等核心环节。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f802e45762ab994d52e03d57a8ebb996","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979388","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","CHAT","ARTY","AGIX","BK1141","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628790619","title":"港股异动 | 英矽智能涨超14%，在AI驱动研发方面取得显著进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2628790619","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628790619?lang=zh_cn&edition=full","pubTime":"2026-04-20 09:53","pubTimestamp":1776649996,"startTime":"0","endTime":"0","summary":"在AI技术与临床开发创新能力上强强联合。","market":"hk","thumbnail":"https://static.tigerbbs.com/3d4a0cd834c35c84d95a2db9c39082a0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3d4a0cd834c35c84d95a2db9c39082a0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f802e45762ab994d52e03d57a8ebb996","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430470.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183122764","title":"异动解读 | 英矽智能盘中大涨8.47%，AACR年会泛KRAS研究成果与AI制药平台进展双重利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1183122764","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183122764?lang=zh_cn&edition=full","pubTime":"2026-04-20 09:41","pubTimestamp":1776649307,"startTime":"0","endTime":"0","summary":"英矽智能今日盘中大涨8.47%，引起了市场的广泛关注。消息面上，AACR年会期间，泛KRAS分子胶/抑制剂成为KRAS赛道最火热的方向，英矽智能作为将公布泛KRAS抑制剂研究结果的重点公司之一受到市场关注。泛KRAS抑制剂可同时靶向多种RAS突变体及野生型蛋白，旨在克服临床中野生型RAS代偿激活导致的耐药难题，被视为KRAS靶向疗法的重要突破方向。此外，英矽智能近期宣布其AI设计的抗纤维化药物已进入II期临床，从靶点发现到临床前候选化合物仅用18个月，远低于传统方法的4至5年周期，进一步验证了其AI制药平台的效率优势，多重利好共振推动股价走强。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627179445","title":"英硅智能(03696)授出370.69万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2627179445","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627179445?lang=zh_cn&edition=full","pubTime":"2026-04-14 20:02","pubTimestamp":1776168178,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能(03696)发布公告，于2026年4月14日，董事会宣布，公司根据首次公开发售后受限制股份单位计划的条款，向合资格人士授出370.69万份受限制股份单位(惟须获受限制股份单位承授人接纳)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120455823","title":"英矽智能3月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1120455823","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120455823?lang=zh_cn&edition=full","pubTime":"2026-04-09 17:03","pubTimestamp":1775725388,"startTime":"0","endTime":"0","summary":"英矽智能于2026年4月9日披露的月报显示，截至2026年3月31日，公司注册股本仍为1,270,000,000股，每股面值0.0000005美元，合计注册股本635美元，与上月底保持一致。已发行股份同样维持在572,402,000股，未发生新增发行、购回或注销。本月经确认公司公众持股比例符合上市规则对于最低公众持股量的要求。公司表示已完成相应董事会批准及法定手续，并确认遵守香港联交所《上市规则》及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128729300","title":"异动解读 | 英矽智能盘中大涨8.98%，新药候选化合物提名及与礼来合作提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1128729300","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128729300?lang=zh_cn&edition=full","pubTime":"2026-04-09 10:27","pubTimestamp":1775701620,"startTime":"0","endTime":"0","summary":"英矽智能(03696)今日盘中大涨8.98%，引起了市场的广泛关注。消息面上，公司宣布提名ISM6200为临床前候选化合物，这是一款潜在同类最佳的NR3C1抑制剂，用于治疗卵巢癌、库欣综合征等与皮质醇过高相关的疾病，展现了其在人工智能药物研发领域的突破。此外，公司近期与礼来达成了一项总额最高约27.5亿美元的对外授权与全球研发合作，其中首付款高达1.15亿美元，这项合作不仅涉及管线授权，还将在英矽智能的Pharma.AI平台赋能下开展多项研发，显著增强了市场对公司技术价值和长期增长前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626697418","title":"港股异动 | 英硅智能(03696)早盘涨超9% 公司提名潜在“同类最佳”NR3C1选择性拮抗剂ISM6200","url":"https://stock-news.laohu8.com/highlight/detail?id=2626697418","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626697418?lang=zh_cn&edition=full","pubTime":"2026-04-09 10:04","pubTimestamp":1775700273,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英硅智能早盘涨超9%，截至发稿，涨4.49%，报61.7港元，成交额1.3亿港元。消息面上，4月8日，英硅智能宣布提名ISM6200，一款强效、潜在同类最佳的NR3C1抑制剂为临床前候选化合物，用于治疗卵巢癌、库欣综合征，以及包括高糖皮质激素相关的肥胖在内的其他与皮质醇过高相关的疾病。值得注意的是，英硅智能3月底发布公告，与礼来达成一项总额最高约27.5亿美元的对外授权与全球研发合作，其中首付款高达1.15亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","03696","BK4585","BK1141","VXUS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://insilico.com","stockEarnings":[{"period":"1week","weight":-0.1765},{"period":"1month","weight":-0.1226},{"period":"3month","weight":-0.2796},{"period":"6month","weight":1.2017},{"period":"ytd","weight":0.4257}],"compareEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":0.0006},{"period":"3month","weight":-0.0227},{"period":"6month","weight":-0.041},{"period":"1year","weight":0.107},{"period":"ytd","weight":0.013}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"英矽智能是一家主要从事人工智能在制药领域研发的公司。该公司致力于药物发现引擎的研发，并从事联合用药的发现和开发，包括疾病靶点识别、新分子数据生成以及临床试验结果预测。","exchange":"SEHK","name":"英矽智能","nameEN":"INSILICO"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英矽智能(03696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英矽智能,03696,英矽智能股票,英矽智能股票老虎,英矽智能股票老虎国际,英矽智能行情,英矽智能股票行情,英矽智能股价,英矽智能股市,英矽智能股票价格,英矽智能股票交易,英矽智能股票购买,英矽智能股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英矽智能(03696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}